Bruker to pay $2.4m to settle SEC charge of improper payments in China
Bruker Corp will pay $2.4m to settle US SEC charges that employees improperly funded Chinese officials' sightseeing trips to win analytical tech contracts at state labs.
Bruker Corp will pay $2.4m to settle US SEC charges that employees improperly funded Chinese officials' sightseeing trips to win analytical tech contracts at state labs.
Patients and pharmacists can now use smartphones to check biologics are genuine with a new Merck Serono tech launched to combat counterfeiters' growing interest in high-value biopharma drugs.
Asian API makers are turning to ‘out-of-the-box’ Manufacturing Execution Systems (MES) to help manage documentation and control quality, according to IT solutions Werum.
Cancer Treatment Centers of America (CTCA) has selected the WIRB-Copernicus Group (WCG) to be its institutional review board (IRB) and thereby expand its clinical research program.
The US FDA is requiring Pfizer to slap yet another warning label on its antipsychotic Geodon (ziprasidone).